scholarly journals Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma

Cancer ◽  
2005 ◽  
Vol 104 (10) ◽  
pp. 2149-2155 ◽  
Author(s):  
Lee M. Krug ◽  
Vincent A. Miller ◽  
Jyoti Patel ◽  
John Crapanzano ◽  
Christopher G. Azzoli ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Weekly Paclitaxel ◽  
Cell Lung Carcinoma ◽  
Weekly Docetaxel ◽  
Nonsmall Cell Lung Carcinoma ◽  
Randomized Phase Ii

scholarly journals A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma

Cancer ◽  
2003 ◽  
Vol 98 (9) ◽  
pp. 1918-1924 ◽  
Author(s):  
Ji-Youn Han ◽  
Dae Ho Lee ◽  
Hae Young Kim ◽  
Eun Kyung Hong ◽  
Sung Min Yoon ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Cell Lung Carcinoma ◽  
Weekly Docetaxel ◽  
Nonsmall Cell Lung Carcinoma

scholarly journals Randomized Phase II study of two opposite administration sequences of irinotecan and cisplatin in patients with advanced nonsmall cell lung carcinoma

Cancer ◽  
2006 ◽  
Vol 106 (4) ◽  
pp. 873-880 ◽  
Author(s):  
Ji-Youn Han ◽  
Hyeong-Seok Lim ◽  
Dae Ho Lee ◽  
So Young Ju ◽  
Sung Young Lee ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma ◽  
Randomized Phase Ii

scholarly journals Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinoma

Cancer ◽  
2005 ◽  
Vol 104 (12) ◽  
pp. 2759-2765 ◽  
Author(s):  
Ji-Youn Han ◽  
Dae Ho Lee ◽  
Sung Young Lee ◽  
Chun Gun Park ◽  
Hyae Young Kim ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma

scholarly journals A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma

Cancer ◽  
2000 ◽  
Vol 89 (4) ◽  
pp. 774-782 ◽  
Author(s):  
Christos Kosmas ◽  
Nicolas B. Tsavaris ◽  
Aristidis Polyzos ◽  
Haralambos P. Kalofonos ◽  
Evangelos Sepsas ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma

Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma

Cancer ◽  
2005 ◽  
Vol 104 (3) ◽  
pp. 561-569 ◽  
Author(s):  
Edward S. Kim ◽  
Merrill S. Kies ◽  
Frank V. Fossella ◽  
Bonnie S. Glisson ◽  
Sara Zaknoen ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Farnesyltransferase Inhibitor ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma
Sign in / Sign up

Export Citation Format

Share Document